BVF as of March 31, 2019
Portfolio Holdings for BVF
BVF holds 53 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Array BioPharma | 9.3 | $83M | 3.4M | 24.38 | |
| Merus N V (MRUS) | 7.5 | $67M | 4.5M | 14.77 | |
| Blueprint Medicines (BPMC) | 5.1 | $45M | 565k | 80.05 | |
| Kura Oncology (KURA) | 4.6 | $41M | 2.5M | 16.59 | |
| Five Prime Therapeutics | 4.6 | $41M | 3.1M | 13.40 | |
| Ac Immune Sa (ACIU) | 4.2 | $38M | 7.5M | 5.05 | |
| Arcus Biosciences Incorporated (RCUS) | 3.9 | $35M | 2.8M | 12.49 | |
| Infinity Pharmaceuticals (INFIQ) | 3.7 | $33M | 17M | 1.88 | |
| Mirati Therapeutics | 3.5 | $32M | 432k | 73.30 | |
| Cytokinetics (CYTK) | 3.4 | $31M | 3.8M | 8.09 | |
| ArQule | 3.4 | $30M | 6.3M | 4.79 | |
| Replimune Group (REPL) | 2.7 | $25M | 1.6M | 15.22 | |
| Xoma Corp Del (XOMA) | 2.5 | $22M | 1.8M | 12.38 | |
| Molecular Templates | 2.3 | $21M | 3.6M | 5.81 | |
| Dicerna Pharmaceuticals | 2.3 | $21M | 1.4M | 14.65 | |
| Chemocentryx | 2.3 | $20M | 1.5M | 13.89 | |
| Calithera Biosciences | 2.3 | $20M | 3.0M | 6.74 | |
| Xenon Pharmaceuticals (XENE) | 2.0 | $18M | 1.8M | 10.16 | |
| Concert Pharmaceuticals I equity | 1.9 | $17M | 1.4M | 12.07 | |
| Anaptysbio Inc Common (ANAB) | 1.8 | $16M | 220k | 73.05 | |
| Galmed Pharmaceuticals | 1.7 | $15M | 1.9M | 8.17 | |
| Protagonist Therapeutics (PTGX) | 1.6 | $14M | 1.1M | 12.57 | |
| Pieris Pharmaceuticals (PIRS) | 1.5 | $14M | 4.1M | 3.35 | |
| Mersana Therapeutics (MRSN) | 1.5 | $13M | 2.5M | 5.26 | |
| Cytomx Therapeutics (CTMX) | 1.4 | $13M | 1.2M | 10.75 | |
| Biolinerx Ltd-spons | 1.2 | $11M | 26M | 0.43 | |
| Syndax Pharmaceuticals (SNDX) | 1.2 | $10M | 2.0M | 5.25 | |
| Verastem | 1.2 | $10M | 3.5M | 2.96 | |
| Argenx Se (ARGX) | 1.1 | $10M | 81k | 124.85 | |
| Forward Pharma A/s | 1.1 | $10M | 8.5M | 1.18 | |
| Spring Bk Pharmaceuticals In | 1.1 | $10M | 952k | 10.49 | |
| Eiger Biopharmaceuticals | 1.1 | $9.4M | 675k | 13.98 | |
| Vbi Vaccines | 1.0 | $8.8M | 4.7M | 1.87 | |
| Corvus Pharmaceuticals (CRVS) | 0.9 | $8.5M | 2.1M | 4.02 | |
| Mei Pharma | 0.9 | $8.3M | 2.7M | 3.07 | |
| Alpine Immune Sciences (ALPN) | 0.9 | $8.2M | 1.2M | 6.86 | |
| Cti Biopharma | 0.8 | $6.7M | 6.9M | 0.97 | |
| Albireo Pharma | 0.7 | $6.5M | 201k | 32.21 | |
| Voyager Therapeutics (VYGR) | 0.7 | $5.9M | 310k | 19.14 | |
| Spero Therapeutics (SPRO) | 0.7 | $5.9M | 461k | 12.81 | |
| Ovid Therapeutics (OVID) | 0.7 | $5.8M | 3.3M | 1.77 | |
| Erytech Pharma Sa | 0.5 | $4.8M | 625k | 7.60 | |
| Genocea Biosciences | 0.5 | $4.6M | 7.8M | 0.59 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.5 | $4.5M | 1.7M | 2.65 | |
| Oncomed Pharmaceuticals | 0.5 | $4.3M | 4.1M | 1.04 | |
| Vical | 0.3 | $2.7M | 2.3M | 1.20 | |
| Sunesis Pharmaceuticals Inc Ne | 0.3 | $2.8M | 2.3M | 1.22 | |
| Realm Therapeutics | 0.3 | $2.4M | 613k | 3.93 | |
| Surface Oncology | 0.2 | $2.2M | 452k | 4.77 | |
| Essa Pharma (EPIX) | 0.2 | $2.0M | 580k | 3.43 | |
| Regulus Therapeutics | 0.1 | $1.1M | 1.1M | 1.02 | |
| Contrafect | 0.1 | $760k | 1.9M | 0.40 | |
| Xencor (XNCR) | 0.0 | $28k | 904.00 | 30.97 |
